FDA Completes “Risk-Based” Reg Trilogy With Good Tissue Practices

Manufacturers of tissue products have until May 25 to implement a comprehensive tissue tracking system under the 1Good Tissue Practice (GTP) regulations finalized Nov. 18

More from Archive

More from Medtech Insight